🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How to monitor disease progression and therapy response in wild-type transthyretin amyloid cardiomyopathy? Our efforts led by Svenja Ney and Roman Pfister show there's much work to be done! Check it out: mdpi.com/2625986 #mdpijcm via JCM MDPI MDPI Universität zu Köln

Immune-mediated thrombotic thrombocytopenic purpura, ITP, and AIHA - triple hit in a patient w/systemic lupus erythematodes. Our thoughts on the management of this unusual and complex condition: DOI 10.5414/CNCS111193 pubmed.ncbi.nlm.nih.gov/38170038/ #iTTP #ITP #Lupus

Our work on #LongCovid 🩸 is now out in Science Magazine! We found increased complement activation and markers of thromboinflammation in patients with active Long Covid. 1/ doi.org/10.1126/scienc…

Mein Gedanken sind bei der Familie des Opfers. Ich fahre täglich mit dem Fahrrad an dieser Stelle entlang. Ein Blick auf die Verkehrsführung und das unkontrollierte Parken hier macht jedem sofort klar, wie egal der Stadt Köln die Sicherheit der Fahrradfahrer und Fußgänger ist.

One of the most pressing questions in the era of caplacizumab is if iTTP can be managed without plasma exchange! Check out our paper addressing this question: Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange ashpublications.org/blood/article-…

Food is medicine...and what we eat governs outcome in many types of diseases (if not all). This includes solid organ transplantation. Fueling the success of transplantation through nutrition:... : Current Opinion in Organ Transplantation journals.lww.com/co-transplanta…

Our comment on Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine nejm.org/doi/full/10.10… Ralph Wendt and Paul Brinkkötter

🧵Thread on frontline caplacizumab and plasma exchange in TTP🚨 With advancing care for immune thrombotic thrombocytopenic purpura (iTTP), let’s discuss frontline caplacizumab (capla) and the future for therapeutic plasma exchange (TPE) ⤵️ #hemetwitter #TTP #caplacizumab 1/22

What’s new in nephrotic syndrome? An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes ⁦- thanks to all coauthors and great collab w/Ralph Wendt⁩ mdpi.com/2227-9059/12/1…

iTTP treatment w/o plasma exchange -final print version now out! Exploring novel treatment paradigms and alleviating treatment burden with the support of great international colleagues! doi.org/10.1182/blood.…

Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange. This is a real change in treatment of our iTTP patients! Congratulations to the authors for this nice paper ashpublications.org/blood/article/…

Made it to the LBCT session And it is a hyponatremia trial! #KidneyWk

Free scientific illustrations for biologists! 😍 NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations! all freely available in the public domain. Retweet and spread the message! bioart.niaid.nih.gov

1/6 TPE-FREE MANAGEMENT OF IMMUNE TTP (iTTP) Retrospective study from Austria and Germany ADAMTS13 activity at baseline <10% in all patients Treatment group (TPE-free): 42 acute iTTP episodes in 41 patients received TPE-free management with caplacizumab + steroids +/- Ritux

🚨 The Capla1000+ project published! Early use of caplacizumab significantly reduces mortality and time to response. 💥 3-mo survival: 98.5% vs. 94% (controls) 🩸 Bleeding in 2.4%, mostly elderly 💡 Age key mortality factor 🔗tinyurl.com/fpx8uuvp #TTP #Caplacizumab

1/ 🚨 Big news from our Genes&Kidney Working Group at the ERA - European Renal Association We just released a consensus statement in Nephrology Dialysis Transplantation aiming to bring us closer to precision medicine in CKD. 🧬🩺 🧵 THREAD 👇